The Jumpstart Our Business Startup (JOBS) Act
The Jumpstart Our Business Startup (JOBS) Act marks a key departure from the previous one-size-fits-all regulatory approach for companies conducting a public offering. Emerging growth companies are now subject to a new regulatory regime, designed to relax their compliance burden as compared to larger and more complex issuers. The law incentivizes and encourages capital formation for small, emerging biotechnology companies that do not yet have products on the market. By allowing companies to focus their limited funds on research rather than on compliance, it will speed the development of new cures and treatments for patients living with debilitating diseases such as cancer, diabetes, Parkinson’s, and HIV/AIDS.